Evaluation of COVID-19 vaccination strategies with a delayed second dose
지연된 2차 접종을 통한 코로나19 예방접종 전략 평가
Research Article
[키워드] acute respiratory syndrome coronavirus
Administered
administration
agent
approved
benefit
calibrated
Characteristics
clinical trials
conditions
contagious
coronavirus
coronavirus 2
coronavirus disease
Coronavirus disease 2019
COVID-19
COVID-19 transmission
COVID-19 vaccination
credible interval
death
determine
distribution
dose
doses
Effectiveness
Efficacy
first dose
Hospitalization
hospitalizations
individual
infections
Moderna
Pfizer
Pfizer-BioNTech
Preexisting immunity
program effectiveness
reducing
respiratory
SARS-CoV-2
second dose
severe acute respiratory syndrome coronavirus 2
Spread
tested
the United State
time interval
United States
vaccinate
vaccination
Vaccination strategies
Vaccine
vaccine efficacy
Vaccines
variants
[DOI] 10.1371/journal.pbio.3001211 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pbio.3001211 PMC 바로가기 [Article Type] Research Article